Amanda N. Sacino

Amanda N. Sacino

Auto-generated profile, based on publicly available information

Amanda N. Sacino

College of Medicine, University of Florida

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2013 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
ASAmanda N Sacino
Amanda N Sacino
MBMieu Brooks
Mieu Brooks
NMNicholas H McGarvey
Nicholas H McGarvey
AMAlex B McKinney
Alex B McKinney
MTMichael A Thomas
Michael A Thomas
BGBenoit I Giasson
Benoit I Giasson
Background: α-Synuclein (αS) is the major component of several types of brain inclusions including Lewy bodies, a hallmark of Parkinson’s disease. Aberrant aggregation of αS also is associated with cellular demise in multiple neurologic disorders collectively referred to as synucleinopathies. Recent studies demonstrate the induction of αS pathology by a single intracerebral injection of exogenous amyloidogenic αS in adult non-transgenic and transgenic mice expressing human αS. To further investigate the mechanism of pathology induction and evaluate an experimental paradigm with potential for higher throughput, we performed similar studies in neonatal mice injected with αS. Results: In non-transgenic mice, we observed limited induction of neuronal αS inclusions predominantly 8 months after brain injection of aggregated, amyloidogenic human αS. More robust inclusion pathology was induced in transgenic mice expressing wild-type human αS (line M20), and inclusion pathology was observed at earlier time points. Injection of a non-amyloidogenic (Δ71-82) deletion protein of αS was also able to induce similar pathology in a subset of M20 transgenic mice. M20 transgenic mice injected with amyloidogenic or non-amyloidogenic αS demonstrated a delayed and robust induction of brain neuroinflammation that occurs in mice with or without αS pathological inclusions implicating this mechanism in aggregate formation. Conclusions: The finding that a non-amyloidogenic Δ71-82 αS can induce pathology calls into question the simple interpretation that exogenous αS catalyzes aggregation and spread of intracellular αS pathology solely through a nucleation dependent conformational templating mechanism. These results indicate that several mechanisms may act synergistically or independently to promote the spread of αS pathology.

28 May 2013 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
ASAmanda N Sacino
Amanda N Sacino
MTMichael A Thomas
Michael A Thomas
CCCarolina Ceballos-Diaz
Carolina Ceballos-Diaz
PCPedro E Cruz
Pedro E Cruz
ARAwilda M Rosario
Awilda M Rosario
TGTodd E. Golde
Todd E. Golde
Background: Genetic studies have established a causative role for α-synuclein (αS) in Parkinson’s disease (PD), and the presence of αS aggregates in the form of Lewy body (LB) and Lewy neurite (LN) protein inclusions are defining pathological features of PD. Recent data has established that extracellular αS aggregates can induce intracellular αS pathologies supporting the hypothesis that αS pathology can spread via a “prion-like” self-templating mechanism.Results: Here we investigated the potential for conformational templating of αS intracellular aggregates by seeding using recombinant wild-type and PD-linked mutant (A53T and E46K) αS in primary mixed neuronal-glial cultures. We find that wild-type and A53T αS fibrils predominantly seed flame-like inclusions in both neurons and astrocytes of mixed primary cultures; whereas the structurally distinct E46K fibrils seed punctate, rounded inclusions. Notably, these differences in seeded inclusion formation in these cultures reflect differences in inclusion pathology seen in transgenic mice expressing the A53T or E46K αS mutants. We further show that the inclusion morphology is dictated primarily by the seed applied rather than the form of αS expressed. We also provide initial evidence that αS inclusion pathology can be passaged in primary astrocyte cultures.Conclusion: These studies establish for the first time that αS aggregation in cultured cells can occur by a morphological self-templating mechanism.

30 July 2015 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
NRNicola J. Rutherford
Nicola J. Rutherford
ASAmanda N. Sacino
Amanda N. Sacino
MBMieu Brooks
Mieu Brooks
CCCarolina Ceballos-Diaz
Carolina Ceballos-Diaz
TLThomas B. Ladd
Thomas B. Ladd
BGBenoit I Giasson
Benoit I Giasson
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that is pathologically characterized by loss of dopaminergic neurons from the substantia nigra, the presence of aggregated α-synuclein (αS) and evidence of neuroinflammation. Experimental studies have shown that the cerebral injection of recombinant fibrillar αS, especially in αS transgenic mouse models, can induce the formation and spread of αS inclusion pathology. However, studies reporting this phenomenon did not consider the presence of lipopolysaccharide (LPS) in the injected αS, produced in E. coli, as a potential confound. The objectives of this study are to develop a method to remove the LPS contamination and investigate the differences in pathologies induced by αS containing LPS or αS highly purified of LPS. We were able to remove >99.5 % of the LPS contamination from the αS preparations through the addition of a cation exchange step during purification. The αS pathology induced by injection of fibrils produced from αS containing LPS or purified of LPS, showed a similar distribution pattern; however, there was less spread into the cortex of the mice injected with αS containing higher levels of LPS. As previously reported, injection of αS fibrils could induce astrogliosis, and αS inclusions were present within astrocytes in mice injected with fibrils comprised of αS with or without cation exchange purification. Furthermore, we identified the presence of αS pathology in ependymal cells in both groups of mice, which suggests the involvement of a novel mechanism for spread in this model of αS pathology.

16 May 2015 in Acta Neuropathologica
Verified
Journal Article
Closed access
PDF file
PCParamita Chakrabarty
Paramita Chakrabarty
VIVincent J. Hudson Iii
Vincent J. Hudson Iii
ASAmanda N. Sacino
Amanda N. Sacino
MBMieu My Thi Brooks
Mieu My Thi Brooks
SDSimon D’aLton
Simon D’aLton
BGBenoit I Giasson
Benoit I Giasson

1 January 2012 in Alzheimer's Research & Therapy
Verified
Journal Article
Open access
PDF file
ASAmanda N Sacino
Amanda N Sacino
BGBenoit I Giasson
Benoit I Giasson
Parkinson's disease, the most common movement disorder, results in an insidious reduction for patients in quality of life and ability to function. A hallmark of Parkinson's disease is the brain accumulation of neuronal cytoplasmic inclusions comprised of the protein α-synuclein. The presence of α-synuclein brain aggregates is observed in several neurodegenerative diseases, including dementia with Lewy bodies and Lewy body variant of Alzheimer's disease. These disorders, as a group, are termed synucleinopathies. Mounting evidence indicates that α-synuclein amyloid pathology may spread during disease progression by a prion-like (self-templating alteration in protein conformation) mechanism. Clear in vitro and cell culture data demonstrate that amyloidogenic α-synuclein can readily induce the conversion of other α-synuclein molecules into this conformation. Some data from experimental mouse studies and autopsied brain analyses also are consistent with the notion that a self-promoting process of α-synuclein amyloid inclusion formation may lead to a progressive spread of disease in vivo. However, as pointed out in this review, there are alternative explanations and interpretations for these findings. Therefore, from a therapeutic perspective, it is critical to determine the relative importance and contribution of α-synuclein prionlike spread in disease before embarking on elaborate efforts to target this putative pathogenic mechanism.

1 February 2016
Verified
Journal Article
Closed access
ASAmanda N Sacino
Amanda N Sacino
JSJonathan J Shuster
Jonathan J Shuster
KNKamil Nowicki
Kamil Nowicki
PCPeter J Carek
Peter J Carek
MWMartin P Wegman
Martin P Wegman
KCKu-Lang Chang
Ku-Lang Chang